Identifying and evaluating a disulfidptosis-related gene signature to predict prognosis in colorectal adenocarcinoma patients
- Ming Li 1,2, Jin Wang 3, Yuhao Zhao 4, Changjie Lin 1, Jianqing Miao 1, Xiaoming Ma 1, Zhenyu Ye 1, Chao Chen 5, Ke Tao 2, Pengcheng Zhu 2, Qi Hu 2, Jinbing Sun 2, Jianfeng Gu 2, Shaohua Wei 1
- Ming Li 1,2, Jin Wang 3, Yuhao Zhao 4
- 1Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- 2Department of General Surgery, Changshu Hospital Affiliated to Soochow University, The First People's Hospital of Changshu, Changshu, Jiangsu, China.
- 3School of Public Health, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China.
- 4Department of Biliary and Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
- 5Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
- 0Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a new prognostic model for colon adenocarcinoma (COAD) using 20 disulfidptosis-related genes (DRGs). The model predicts patient outcomes and highlights POU4F1
Area Of Science
- Oncology
- Cell Death Research
- Genomics
Background
- Disulfidptosis, a regulated cell death, is observed in cancers with high SLC7A11 expression.
- Its role in colon adenocarcinoma (COAD) remains under-explored.
- Understanding disulfidptosis in COAD is crucial for developing novel therapeutic strategies.
Purpose Of The Study
- To develop and validate a prognostic model for COAD based on disulfidptosis-related genes (DRGs).
- To investigate the correlation between the risk score and cancer-related biological processes, immune infiltration, and gene expression.
- To elucidate the specific role of POU4F1 in COAD progression and disulfidptosis.
Main Methods
- Utilized LASSO and Cox regression analyses to build a prognostic model from 20 DRGs.
- Developed a nomogram to assess the model's robustness and clinical applicability.
- Performed correlation, enrichment, and in vitro assays to analyze gene functions and cellular responses.
Main Results
- A validated DRG-based prognostic model for COAD patients was established.
- The risk score correlated with key cancer pathways, immune cell infiltration, and oncogene expression.
- POU4F1 was identified as an oncogene in COAD, promoting proliferation and migration, and potentially regulating disulfidptosis.
Conclusions
- The developed DRG-based model offers a valuable tool for predicting COAD patient prognosis.
- POU4F1 plays a significant role in COAD progression and may be a therapeutic target.
- This research sheds light on the role of disulfidptosis in COAD and its relationship with oncogenic pathways.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

